|
|
|
|
| LEADER |
02401nam a22003015i 4500 |
| 001 |
000283574 |
| 005 |
20210506091023.0 |
| 007 |
cr nn 008mamaa |
| 008 |
110212s2011 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781617790126
|
| 024 |
7 |
|
|a 10.1007/978-1-61779-012-6
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Drug Design and Discovery :
|b Methods and Protocols /
|c edited by Seetharama D. Satyanarayanajois.
|
| 250 |
|
|
|a 1st ed. 2011.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2011.
|
| 300 |
|
|
|a XI, 284 p. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Biology,
|v 716
|
| 505 |
0 |
|
|a Virtual Screening for Lead Discovery -- Computer-Aided Drug Discovery and Development -- Using Active Site Mapping and Receptor-Based Pharmacophore Tools: Prelude to Docking and De Novo/Fragment-Based Ligand Design -- Methods for Evaluation of Structural and Biological Properties of Anti-Invasive Natural Products -- Solid-Phase Peptide Synthesis Using Microwave Irradiation -- Fluorescent and Lanthanide Labeling for Ligand Screens, Assays, and Imaging -- DNA-Directed Assembly Microarray for Protein and Small Molecule Inhibitor Screening -- Selection of Peptide Ligands for Human Placental Transcytosis Systems Using In vitro Phage Display -- Optimization of the Tetrazolium Dye (MTT) Colorimetric Assay for Cellular Growth and Viability -- Imaging NF- κB Signaling in Mice for Screening Anti-Cancer Drugs -- Evaluation of Anticancer Agents Using Flow Cytometry Analysis of Cancer Stem Cells -- Chemical Screening with Zebrafish Embryos.- iTRAQTM Labeling Coupled with LC-MALDI Mass Spectrometry for Monitoring Temporal Response of Colorectal Cancer Cells to Butyrate Treatment -- Heterotypic Cell Adhesion Assay for the Study of Cell Adhesion Inhibition -- Evaluation of Antibacterial Activity of Proteins and Peptides Using a Specific Animal Model for Wound Healing -- In vitro Immunogenicity Risk Assessment of Therapeutic Proteins in Preclinical Setting.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Laboratory medicine.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Laboratory Medicine.
|
| 700 |
1 |
|
|a Satyanarayanajois, Seetharama D.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|